EUthyroid project deliverables
The page lists 11 deliverables related to the research project "EUthyroid".
List of Deliverables
| title and desprition | type | last update |
|---|---|---|
Association between repeated UICr measurements and IQ establishedPrimary endpoint: We will investigate whether mean child IQ levels differ according to mild-to-moderate iodine deficiency (classified using repeated urinary iodine measurements, see Tasks 4.2. and 4.4) by using multivariate linear regression models and combining the individual data from the three cohorts (see Task 4.1). Furthermore, we will investigate whether the iodine status is associated with the risk of learning disabilities (IQ<85) by using multivariate logistic regression analyses. (minimum odds ratio of 1.2 detectable as statistically significant). Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Joint European database prepared for combining national/or regional registry outcome data related to iodine statusThe first task related to WP1 is to request the 22 national representatives involved in EUthyroid to get access to relevant data from registries in their respective countries. Requested registry data includes numbers of patients registered with relevant disease codes according to the ICD-10 system by WHO (E00-E07 including subcodes and C73), numbers of thyroid surgery and fine needle biopsy procedures performed, numbers of radio-iodine doses applied, and sales figures of relevant medication (ATC-codes H03A+H03B). Data from at least the past three years will be requested. Approval from local ethical committees will be obtained if required. As national registry data becomes available, a joint database will be built up at CCRP. The database will include measures of thyroid related disorders and treatments in addition to demographic data describing the distributions of age and gender in the different European populations. Tight communication between WP1 and WP2 will ensure a common structure of the two WP databases. In collaboration with the principal investigator of WP1, handling and documentation of the database will be carried out by an experienced data manager. The joint database will constitute a model for future Pan-European data collections aiming to monitor the effects of IDD prevention programmes. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Statistical analyses of associations between registry based outcome variables and actual iodine status finalisedWhen results regarding the current iodine status are available from WP2 statistical analyses of associations between registry-based outcome variables and current iodine status will be performed to show a more detailed picture of the association between iodine intake and IDD-related outcomes across Europe. These analyses will take into account that the actual intake of iodine may vary considerably among countries irrespective of the presence of IDD prevention programs. Special emphasis will be laid on the incidence of hypothyroidism and autoimmune thyroid disease and related treatments. IDD prevention in the country will be defined as best-practice model that will have no socioeconomic gradient in the efficacy of the IDD prevention as well as the most balanced relation between a low prevalence/ decrease of IDD-related outcomes and low prevalence/ increase of hypothyroidism and autoimmune thyroid disease. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Report on the identification of a best-practice model of IDD prevention availableWhen results regarding the current iodine status are available from WP2 statistical analyses of associations between registry-based outcome variables and current iodine status will be performed to show a more detailed picture of the association between iodine intake and IDD-related outcomes across Europe. These analyses will take into account that the actual intake of iodine may vary considerably among countries irrespective of the presence of IDD prevention programs. Special emphasis will be laid on the incidence of hypothyroidism and autoimmune thyroid disease and related treatments. IDD prevention in the country will be defined as best-practice model that will have no socioeconomic gradient in the efficacy of the IDD prevention as well as the most balanced relation between a low prevalence/ decrease of IDD-related outcomes and low prevalence/ increase of hypothyroidism and autoimmune thyroid disease. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Iodine status assessed by repeated UIC measurementsRepeated gestational maternal UIC/creatinine ratio (UICcr) measurements have not yet been studied in such large numbers. We will therefore first investigate the classification and determinant characteristics. We will study to what extent first trimester UICcr measurements (currently used in most clinical studies) correlate to second and third trimester UICcr measurements. Furthermore, we will investigate which maternal and pregnancy characteristics are determinants of UICcr levels, or of the gestational variation in UICcr levels by using (non)linear mixed models. Future analyses can then be adjusted and/or stratified accordingly. Subsequently, iodine status will be classified according to the number of (ab)normal samples. Three groups will be created:1) iodine sufficient: women in which all samples measured a UICcr of >150 µg/L; 2) borderline insufficient status: women in which one sample measured a UICcr of <150 µg/L, 3) iodine insufficient: women with all, or 2/3 samples with a UICcr of <150 µg/L. Sensitivity analyses will be performed in order to investigate UICcr variation in women with borderline iodine status (mean UICcr >150 µg/L vs. <150 µg/L) and to investigate possible severe iodine insufficiency (at least one sample UICcr < 50 µg/L). Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Training modules finalised on EUthyroid websitesTo reduce bias by study staff, a training programme will be established. All training procedures will be established web-based to minimise costs. The training tool will include standard operating procedures as well as graphical and cinematic visualisation of key points and main pitfalls in conducting interviews, blood and urine sampling, laboratory analyses and thyroid ultrasound. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Tg as a risk biomarker of iodine deficiency in pregnancy for neurocognitive function of the offspring evaluatedThe potential of Tg as a risk biomarker in pregnancy for neurocognitive function of the offspring will be tested. Applying methods described in Task 3.1, WP3 will measure serum Tg in 3500 samples of the WP4 studies in pregnant women whose children have neurocognitive data, and the meta-analysis detailed in Task 4.5b will be done. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-10-08 |
Web-based training and certification tools onlineSince the mean thyroid size in population samples reflects the iodine status, most of the regional surveys will include thyroid ultrasound measurements. To minimise the bias across the studies, a web-based reader certification tool will be established. Beyond the information integrated in the training tool (see Task 2.4), ultrasound observers will be offered to be certificated according to the standards of the Study of Health in Pomerania (SHIP)32. From a pool of 100 ultrasound images, each observer has to read a randomly selected set of 2 x 25 ultrasound images for dimensions of the thyroid lobes. The results of the readings will be analysed for intra- and inter-observer differences and compared to the readings of two EUthyroid expert sonographers. Statistical analyses will be performed using Bland & Altman plots; a mean bias of ± 5% and a 2SD of ± 25% must not be exceeded. In case a certification will have not been passed, the procedure can be repeated after a new training cycle. After successful certification, a EUthyroid certificate can be printed out, indicating that the exam was passed was passed by the reader. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-06-05 |
Communication plan establishedThe communication plan will fix all relevant issues for an optimised dissemination strategy including target audiences, distribution lists, national contact lists for regional monitors, the selection of appropriate measures and tools in specific areas of communication and the definition of key messages. The communication plan will outline risk factors and counter measures regarding the strategic aims of the dissemination and will be updated continuously during the lifetime of the project. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-06-05 |
Website publishedWP6 will create a multilingual website (consumer and publicly accessible). It will be the main information resource for EUthyroid describing the project objectives and phases, work areas, main results, publications and links to relevant websites. The content of the EUthyroid website will be divided in sections for the various stakeholder groups based on the requirements defined in the communication plan. The content will be regularly updated with input of all partners to keep interested stake holders and the public informed of the project’s objectives and progress as well as general issues about iodine deficiency. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-06-05 |
Infrastructure of the data transfer unit establishedA joint database will be established to collect and pool standardised national and regional IDD monitoring data. The University Medicine Greifswald will also take responsibility to back-up the WP1 database on registry data. Both the WP and WP2 databases will be organised according to identical standards. The University Medicine Greifswald will be in charge for the maintenance of the centralised databases and the transfer of EUthyroid data to the scientific community. Existing data infrastructure established for large-scale population and patient studies will be extended by experienced computer scientists and data managers. The data management is described in more detail in section 2.2.1.1. Programme: H2020-EU.3.1.2. - Topic(s): PHC-06-2014 |
Documents, reports | 2019-06-05 |